Tabanao, Jhon Mike V.
HRN: 22-82-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/05/2023
04/11/2023
IV
375
OD
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes